These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35686294)

  • 1. Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn's disease in tuberculosis endemic areas.
    Sachdeva K; Kumar P; Kante B; Vuyyuru SK; Mohta S; Ranjan MK; Singh MK; Verma M; Makharia G; Kedia S; Ahuja V
    Intest Res; 2023 Apr; 21(2):226-234. PubMed ID: 35686294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review with meta-analysis: accuracy of interferon-gamma releasing assay and anti-Saccharomyces cerevisiae antibody in differentiating intestinal tuberculosis from Crohn's disease in Asians.
    Ng SC; Hirai HW; Tsoi KK; Wong SH; Chan FK; Sung JJ; Wu JC
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1664-70. PubMed ID: 24910240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of TB-IGRA may help to differentiate between intestinal tuberculosis and Crohn's disease in patients with positive results.
    Zhao Y; Xu M; Chen L; Liu Z; Sun X
    Therap Adv Gastroenterol; 2020; 13():1756284820922003. PubMed ID: 32523624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in clinical features of Crohn's disease and intestinal tuberculosis.
    Huang X; Liao WD; Yu C; Tu Y; Pan XL; Chen YX; Lv NH; Zhu X
    World J Gastroenterol; 2015 Mar; 21(12):3650-6. PubMed ID: 25834333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of the clinical utility of interferon-γ assay in the differential diagnosis of intestinal tuberculosis and Crohn's disease.
    Kim BJ; Choi YS; Jang BI; Park YS; Kim WH; Kim YS; Jung SA; Han DS; Kim JS; Choi JH; Choi CH; Jeen YT; Cheon JH; Ye BD; Yang SK; Kim YH
    Inflamm Bowel Dis; 2011 Jun; 17(6):1308-13. PubMed ID: 21053248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of in vitro interferonγ-release assay in differentiating intestinal tuberculosis from Crohn's disease in China.
    Li Y; Zhang LF; Liu XQ; Wang L; Wang X; Wang J; Qian JM
    J Crohns Colitis; 2012 Apr; 6(3):317-23. PubMed ID: 22405168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superiority of Interferon Gamma Assay Over Tuberculin Skin Test for Latent Tuberculosis in Inflammatory Bowel Disease Patients in Brazil.
    Amorim RF; Viegas ERC; Carneiro AJV; Esberard BC; Chinem ES; Correa RS; Rodrigues L; Ribeiro-Alves M; Silva KS; de Souza HS; Carvalho ATP
    Dig Dis Sci; 2019 Jul; 64(7):1916-1922. PubMed ID: 30673986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of in vitro interferon-γ release assay in differential diagnosis between intestinal tuberculosis and Crohn's disease.
    Lei Y; Yi FM; Zhao J; Luckheeram RV; Huang S; Chen M; Huang MF; Li J; Zhou R; Yang GF; Xia B
    J Dig Dis; 2013 Feb; 14(2):68-75. PubMed ID: 23176201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Interferon Gamma Release Assay and Tuberculin Skin Test for Diagnosis of Latent Tuberculosis in Psoriasis Patients Planned for Systemic Therapy.
    Neema S; Sandhu S; Mukherjee S; Vashisht D; Vendhan S; Sinha A; Vasudevan B
    Indian J Dermatol; 2022; 67(1):19-25. PubMed ID: 35656280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying logistic LASSO regression for the diagnosis of atypical Crohn's disease.
    Li Y; Lu F; Yin Y
    Sci Rep; 2022 Jul; 12(1):11340. PubMed ID: 35790774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
    Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
    J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease.
    Kurti Z; Lovasz BD; Gecse KB; Balint A; Farkas K; Morocza-Szabo A; Gyurcsanyi A; Kristof K; Vegh Z; Gonczi L; Kiss LS; Golovics PA; Lakatos L; Molnar T; Lakatos PL
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):467-72. PubMed ID: 26697573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of clinical and endoscopic findings in differentiating Crohn's disease from intestinal tuberculosis.
    Li X; Liu X; Zou Y; Ouyang C; Wu X; Zhou M; Chen L; Ye L; Lu F
    Dig Dis Sci; 2011 Jan; 56(1):188-96. PubMed ID: 20467901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of interferon-gamma release assays for differentiating intestinal tuberculosis from Crohn's disease: a meta-analysis.
    Chen W; Fan JH; Luo W; Peng P; Su SB
    World J Gastroenterol; 2013 Nov; 19(44):8133-40. PubMed ID: 24307809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-Analytic Bayesian Model For Differentiating Intestinal Tuberculosis from Crohn's Disease.
    Limsrivilai J; Shreiner AB; Pongpaibul A; Laohapand C; Boonanuwat R; Pausawasdi N; Pongprasobchai S; Manatsathit S; Higgins PD
    Am J Gastroenterol; 2017 Mar; 112(3):415-427. PubMed ID: 28045023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of increased visceral fat and long segment involvement: Development and validation of an updated imaging marker for differentiating Crohn's disease from intestinal tuberculosis.
    Kedia S; Madhusudhan KS; Sharma R; Bopanna S; Yadav DP; Goyal S; Jain S; Das P; Dattagupta S; Makharia G; Ahuja V
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1234-1241. PubMed ID: 29205485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring frequency of interferon gamma release assay for tuberculosis surveillance following infliximab therapy in patients with Crohn's disease.
    Yang QY; Liu YJ; Xu Y; Zhang L; Wang CD
    J Dig Dis; 2021 Aug; 22(8):473-480. PubMed ID: 34240823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-γ assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis.
    Kim YS; Kim YH; Kim WH; Kim JS; Park YS; Yang SK; Ye BD; Jang BI; Jung SA; Jeen YT; Cheon JH; Choi YS; Choi JH; Kim BJ; Choi CH; Han DS
    Clin Chim Acta; 2011 Aug; 412(17-18):1527-32. PubMed ID: 21575618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Novel Diagnostic Nomogram to Differentiate Between Intestinal Tuberculosis and Crohn's Disease: A 6-year Prospective Multicenter Study.
    He Y; Zhu Z; Chen Y; Chen F; Wang Y; Ouyang C; Yang H; Huang M; Zhuang X; Mao R; Ben-Horin S; Wu X; Ouyang Q; Qian J; Lu N; Hu P; Chen M
    Am J Gastroenterol; 2019 Mar; 114(3):490-499. PubMed ID: 30741735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.